Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice


Mutation of the retinoblastoma tumour-suppressor gene (RB) leads to the deregulation of many proteins and transcription factors that interact with the retinoblastoma gene product (pRB), including members of the E2F transcription factor family1,2. As pRB is known to repress E2F transcriptional activity and overexpression of E2F is sufficient for cell cycle progression, it is thought that pRB suppresses growth in part by repressing E2F-mediated transcription3. Previously, we reported that loss of E2f1 in mice results in tissue-specific tumour induction and tissue atrophy4, demonstrating that E2F-1 normally controls growth both positively and negatively in a tissue-specific fashion4,5. To determine whether E2F-1 deregulation—as a result of loss of pRB—promotes proliferation in vivo, we have tested whether loss of E2f1 interferes with the pituitary and thyroid tumorigenesis that occurs in Rb1(+/−) mice6–9. We have found that loss of E2f1 reduces the frequency of pituitary and thyroid tumours, and greatly lengthens the lifespan of Rb1(+/−); E2f1(−/−) animals, demonstrating that E2F-1 is an important downstream target of pRB during tumorigenesis. Furthermore, loss of E2f1 reduces a previously reported strain-dependent difference in Rb1(+/−) lifespan9,10, suggesting that E2f1 or an E2F-1-regulated gene acts as a genetic modifier between the 129/Sv and C57BL/6 strains.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Riley, D.J., Lee, E.Y. & Lee, W.-H. The retinoblastoma protein: more than a tumor suppressor. Annual Rev. Cell Biol. 10, 1–29 (1994).

    CAS  Article  Google Scholar 

  2. 2

    Horowitz, J.M. & Udvadia, A.J. Transcriptional regulation by the Retinoblastoma (Rb) protein. Mol. Cell. Differ. 3, 275–314 (1995).

    CAS  Google Scholar 

  3. 3

    Slansky, J.E. & Farnham, P.J. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208, 1–30 (1996).

    CAS  PubMed  Google Scholar 

  4. 4

    Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537–548 (1996).

    CAS  Article  Google Scholar 

  5. 5

    Field, S.J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549–561 (1996).

    CAS  Article  Google Scholar 

  6. 6

    Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).

    CAS  Article  Google Scholar 

  7. 7

    Harrison, D.J., Hooper, M.L., Armstrong, J.F. & Clarke, A.R. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10, 1615–1620 (1995).

    CAS  PubMed  Google Scholar 

  8. 8

    Hu, N. et al. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021–1027 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9

    Williams, B.O. et al. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet. 7, 480–484 (1994).

    CAS  Article  Google Scholar 

  10. 10

    Williams, B.O. et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251–4259 (1994).

    CAS  Article  Google Scholar 

  11. 11

    Sherr, C.J. Cancer cell cycles. Science 274, 1672–1677 (1996).

    CAS  Article  Google Scholar 

  12. 12

    Johnson, D.G., Schwarz, J.K., Cress, W.D. & Nevins, J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349–352 (1993).

    CAS  Article  Google Scholar 

  13. 13

    Qin, X.-Q., Livingston, D.M., Kaelin, W.G.J. & Adams, P. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91, 10918–10922 (1994).

    CAS  Article  Google Scholar 

  14. 14

    Shan, B. & Lee, W.-H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166–8173 (1994).

    CAS  Article  Google Scholar 

  15. 15

    Kowalik, T.F., DeGregori, J., Schwarz, J.K. & Nevins, J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491–2500 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16

    Johnson, D.G., Cress, W.D., Jakoi, L. & Nevins, J.R. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91, 12823–12827 (1994).

    CAS  Article  Google Scholar 

  17. 17

    Singh, P., Wong, S.H. & Hong, W. Overexpression of E2F-1 in rat embryo f ibroblasts leads to neoplastic transformation. EMBO J. 13, 3329–3338 (1994).

    CAS  Article  Google Scholar 

  18. 18

    Xu, G., Livingston, D.M. & Krek, W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92, 1357–1361 (1995).

    CAS  Article  Google Scholar 

  19. 19

    Wu, X. & Levine, A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91, 3602–3606 (1994).

    CAS  Article  Google Scholar 

  20. 20

    Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840–1852 (1997).

    CAS  Article  Google Scholar 

  21. 21

    Phillips, A.C., Bates, S., Ryan, K.M., Helin, K. & Vousden, K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11, 1853–1863 (1997).

    CAS  Article  Google Scholar 

  22. 22

    Nip, J. et al. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell. Biol. 17, 1049–1056 (1997).

    CAS  Article  Google Scholar 

  23. 23

    Maandag, E.C.R. et al. Developmental rescue of an embryonic-lethal mutatuion in the retinoblastoma gene in chimeric mice. EMBO J. 13, 4260–4268 (1994).

    CAS  Article  Google Scholar 

  24. 24

    Clarke, A.R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328–330 (1992).

    CAS  Article  Google Scholar 

  25. 25

    Lee, E.Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288–294 (1992).

    CAS  Article  Google Scholar 

  26. 26

    Macleod, K.F., Hu, Y. & Jacks, T. Loss of RB activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15, 6178–6188 (1996).

    CAS  Article  Google Scholar 

  27. 27

    Bronson, R.T. Rate of occurrence of lesions in 20 inbred and hybrid genotypes of rats and mice sacrificed at 6 month intervals during the first years of life. in Genetic Effects on Aging II (ed. Harrison, D.E.) 279–358 (Telford Press, Inc., Caldwell, New Jersey, 1990).

    Google Scholar 

  28. 28

    Simpson, E.M. et al. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16, 19–27 (1997).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Lili Yamasaki.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yamasaki, L., Bronson, R., Williams, B. et al. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice. Nat Genet 18, 360–364 (1998).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing